FDA News
🇺🇸 FDA Page 31FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 361–372 of 391 articles
FDA Accepts Praxis Precision Medicines' New Drug Application for Ulixacaltamide HCl Essential Tremor Treatment
FDA · 2 min
Dr. Sarah MitchellFDA Approves FILSPARI (Sparsentan) for FSGS: First Treatment for Rare Kidney Disease
FDA · Nephrology - Focal Segmental Glomerulosclerosis (FSGS) · 4 min
Dr. Sarah MitchellFDA Approves LumaGen Gene Therapy for Inherited Retinal Disease
FDA · Inherited Retinal Disease · 8 min
Dr. Sarah MitchellFDA Approves Biosimilar Insulin Lispro: What You Need to Know
FDA · Diabetes Mellitus · 4 min
Dr. Sarah MitchellFDA Approves OsteoBuild: New Bone-Building Agent for Severe Osteoporosis
FDA · Osteoporosis · 5 min
Dr. Sarah MitchellFDA Priority Review Granted to PharmaGiant's CholesterolRx for High Cholesterol
FDA · Cardiovascular · 6 min
Dr. Sarah MitchellTelemedicine Pharmaceutical Access: What You Need to Know (FDA Insights)
FDA · Chronic Disease Management · 11 min
Dr. Sarah MitchellFDA Approves SomniRestore: New Chronic Insomnia Treatment
FDA · Chronic Insomnia · 6 min
Dr. Sarah MitchellFDA Approves LysoClear: New Treatment for Lysosomal Storage Disorders
FDA · Lysosomal Storage Disorders · 7 min
Dr. Sarah MitchellFDA Launches Manufacturing PreCheck Pilot Program to Streamline Drug Production Oversight
FDA · 2 min
Dr. Sarah MitchellReal-World Evidence Transforms Drug Development as FDA Expands Regulatory Framework
FDA · 2 min
Dr. Sarah MitchellFDA Releases Updated Database of Untitled Letters for Pharmaceutical Marketing Violations
FDA · 2 min
Dr. Sarah MitchellExplore intelligence